PET imaging of brain cancer with positron emitter-labeled liposomes

International Journal of Pharmaceutics

Volumn 403, Issue 1-2, 2011, Pages 170-177

  Oku, Naoto ^a   Yamashita, Mina ^a   Katayama, Yurie ^a   Urakami, Takeo ^a,c   Hatanaka, Kentaro ^a   Shimizu, Kosuke ^a   Asai, Tomohiro ^a   Tsukada, Hideo ^b   Akai, Shuji ^a   Kanazawa, Hiroaki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b CENTRAL RESEARCH LABORATORY   (Japan)

^c Burnham Institute for Medical Research at Lake Nona   (United States)

Author keywords

Angiogenesis; Brain cancer; Cancer diagnosis; Liposome; Passive targeting; Positron emission tomography

Indexed keywords

ANGIOGENIC FACTOR; FLUORODEOXYGLUCOSE F 18; LIPOSOME; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN TISSUE; FLUORESCENCE; GLIOMA; MALE; NONHUMAN; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ALKANES; ANIMALS; AUTORADIOGRAPHY; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; LIPOSOMES; MALE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344;

EID: 78650172029     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.10.001     Document Type: Article

References (39)

1. T. Asai, K. Shimizu, M. Kondo, K. Kuromi, K. Watanabe, K. Ogino, T. Taki, S. Shuto, A. Matsuda, and N. Oku Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels FEBS Lett. 520 2002 167 170 (Pubitemid 34607294)
2. P.K. Brastianos, and T.T. Batchelor VEGF inhibitors in brain tumors Clin. Adv. Hematol. Oncol. 768 2009 753 760
3. W. Chen Clinical applications of PET in brain tumors J. Nucl. Med. 48 2007 1468 1481
4. T.A. Elbayoumi, and V.P. Torchilin Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies Eur. J. Nucl. Med. Mol. Imaging 33 2006 1196 1205
5. 18Ffluoroethyl)-l-tyrosine PET and MRI in low-grade glioma J. Nucl. Med. 48 2007 519 527
6. A.A. Gabizon Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy Cancer Invest. 19 2001 424 436
7. L. Geng, K. Osusky, S. Konjeti, A. Fu, and D. Hallahan Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay J. Control. Release 99 2004 369 381
8. M. Hamoudeh, M.A. Kamleh, R. Diab, and H. Fessi Radionuclide delivery systems for nuclear imaging and radiotherapy of cancer Adv. Drug Deliv. Rev. 60 2008 1329 1346
9. 18F- fluorothymidine (FLT) PET in patients with newly diagnosed glioma Eur. J. Nucl. Med. Mol. Imaging 35 2008 2009 2017
10. 18F]fluoroethyl)-l-tyrosine in vitro and in vivo J. Nucl. Med. 40 1999 1367 1673
11. 18F]fluoromethyl-l-tyrosine as tumor imaging tracers by PET Nucl. Med. Biol. 31 2004 191 198
12. P.L. Jager, W. Vaalburg, J. Pruim, E.G. de Vries, K.J. Langen, and D.A. Piers Radiolabeled amino acids: basic aspects and clinical applications in oncology J. Nucl. Med. 42 2001 432 445
13. 11C-choline positron-emission tomography AJNR Am. J. Neuroradiol. 29 2008 1176 1182
14. M. Kondo, T. Asai, Y. Katanasaka, Y. Sadzuka, H. Tsukada, K. Ogino, T. Taki, K. Baba, and N. Oku Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase Int. J. Cancer 108 2004 301 306
15. K. Kostarelos, and D. Emfietzoglou Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals Anticancer Res. 20 2000 3339 3345
16. 18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications Nucl. Med. Biol. 33 2006 287 294
17. H. Maeda, J. Wu, T. Saw, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
18. H. Maeda, G.Y. Bharate, and J. Daruwalla Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect Eur. J. Pharm. Biopharm. 71 2009 409 419
19. N. Maeda, Y. Takeuchi, M. Takada, Y. Sadzuka, Y. Namba, and N. Oku Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome J. Control. Release 100 2004 41 52
20. N. Maeda, S. Miyazawa, K. Shimizu, T. Asai, S. Yonezawa, S. Kitazawa, Y. Namba, H. Tsukada, and N. Oku Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs Biol. Pharm. Bull. 29 2006 1936 1940
21. 18F]fluoroethyl)-l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment J. Neurooncol. 88 2008 27 35
22. Y. Nakamoto, K. Togashi, T. Kaneta, H. Fukuda, K. Nakajima, K. Kitajima, K. Murakami, H. Fujii, M. Satake, U. Tateishi, K. Kubota, and M. Senda Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study Jpn. J. Clin. Oncol. 39 2009 297 302
23. 11C] methionine into astrocytomas and oligodendrogliomas J. Neurooncol. 93 2009 233 241
24. N. Oku, Y. Tokudome, H. Tsukada, T. Kosugi, Y. Namba, and S. Okada In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography Biopharm. Drug Dispos. 17 1996 435 441
25. N. Oku, T. Asai, K. Watanabe, K. Kuromi, M. Nagatsuka, K. Kurohane, H. Kikkawa, K. Ogino, M. Tanaka, D. Ishikawa, H. Tsukada, M. Momose, J. Nakayama, and T. Taki Anti-neovascular therapy using novel peptides homing to angiogenic vessels Oncogene 21 2002 2662 2669 (Pubitemid 34478324)
26. 18F-FDG PET in brain tumors Nucl. Med. Biol. 36 2009 779 787
27. T. Sakakibara, F.A. Chen, H. Kida, K. Kunieda, R.E. Cuenca, F.J. Martin, and R.B. Bankert Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts Cancer Res. 56 1996 3743 3746
28. A.M. Scott, D.H. Gunawardana, D. Bartholomeusz, J.E. Ramshaw, and P. Lin PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study J. Nucl. Med. 49 2008 1593 1600
29. S. Standring GRAY'S Anatomy 39th ed. 2005 Elsevier Edinburgh pp. 51-52
30. A.M. Syme, S.A. McQuarrie, J.W. Middleton, and B.G. Fallone Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases Phys. Med. Biol. 48 2003 1305 1320
31. A. Takeda, H. Tamano, and N. Oku Alteration of zinc concentrations in the brain implanted with C6 glioma Brain Res. 965 2003 170 173
32. G. Tang, M. Wang, X. Tang, L. Luo, and M. Gan Synthesis and evaluation of O-(3-[18F]fluoropropyl)-l-tyrosine as an oncologic PET tracer Nucl. Med. Biol. 30 2003 733 739
33. 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors Eur. J. Nucl. Med. Mol. Imaging 31 2004 1064 1172
34. 11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma J. Nucl. Med. 50 2009 1962 1968
35. 18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography J. Med. Chem. 50 2007 6454 6457
36. 18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography Nucl. Med. Biol. 36 2009 295 303
37. J.J. Verhoeff, L.J. Stalpers, A. Claes, K.E. Hovinga, G.D. Musters, W.P. Vandertop, D.J. Richel, W.P. Leenders, and W.R. van Furth Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma Eur. J. Cancer 45 2009 3074 3080
38. P.Y. Wen, and S. Kesari Malignant gliomas in adults N. Engl. J. Med. 359 2008 492 507
39. 18F-FDG-PET Mol. Imaging Biol. 10 2008 281 287